Business Wire

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

BREA, Calif. & TOKYO--(BUSINESS WIRE)--Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today ...
Nasdaq

Beckman Coulter awarded expanded partnership with BARDA to assess sepsis diagnostic and prediction algorithm with COVID-19 patients

BREA, Calif., May 15, 2020 /PRNewswire/ -- Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure ...
News Medical

Beckman Coulter announces contract with CML for high quality diagnostic services

Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, today announced a record contract with ...
Seeking Alpha

Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections

BREA, Calif. and HAIFA, Israel, Jan. 31, 2023 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response ...
Orange County Register

Beckman Coulter buying diagnostic firm and supplier Lumigen

Beckman Coulter Inc., the Fullerton maker of laboratory equipment and instruments, is adding another diagnostic firm to its stable. Beckman said Monday it will buy privately-held Lumigen Inc. of ...